Neurim Pharmaceuticals Ltd.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Tel Aviv Israel (1991)

Organization Overview

First Clinical Trial
1995
NCT00869128
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Neurim Pharmaceutical Ltd. | Neurim Pharmaceuticals Ltd.